INMB vs PNC · rev $50.0K vs P/E 14, rev $6.88B
INmune Bio Inc (INMB) versus PNC Financial Services Group Inc (PNC) — a side-by-side from cached financials, not a winner call.
INmune Bio Inc (INMB) is a biotechnology company listed on US.
PNC Financial Services Group Inc (PNC) is a banks - regional company listed on US.
Latest reported INMB revenue for 2025-09-30 was $50.0K. Net income was -$6.5M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. INMB currently screens at market cap $33.5M.
Latest reported PNC revenue for 2026-06-30 was $6.88B. Net income was $2.04B. Revenue was up 11.5% from 2026-03-31 to 2026-06-30. PNC currently screens at market cap $77.76B and trailing P/E 13.9.
INMB currently screens at market cap $33.5M. PNC currently screens at market cap $77.76B and trailing P/E 13.9.
Not investment advice. Open the INMB and PNC stock pages for the full models.
Not investment advice.